logo

For the Inventor, By the Inventor

Vancouver, Canada

Ethan D Sternberg

USPTO Granted Patents = 16


Average Co-Inventor Count = 4.2

ph-index = 7

Forward Citations = 297(Granted Patents)


Company Filing History:

goldMedal15 out of 932 
 
The University of British Columbia
 patents
silverMedal1 out of 15 
 
Qlt Phototherapeutics, Inc.
 patents
bronzeMedal1 out of 1 
 
Qlt Phototherapeutices Inc.
 patent
4. 1 out of 1 
 
Qlt, Inc. and
 patent
5. 1 out of 832,843 
Other
 patents
where one patent can have more than one assignee

Years Active: 1990-2006

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 7122569 - Ethylene glycol esters as photoactive agents (2006-10-17),
2. 6894161 - Methods and compositions for photo-cross linking photoactive compounds to target tissue (2005-05-17),
3. 6878253 - Chiral separation of benzoporphyrin derivative mono-and di-acids by laser-induced fluorescence capillary electrophoresis (2005-04-12),
4. 6825343 - 1,3-dipolar cycloadditions to polypyrrolic macrocycles (2004-11-30),
5. 6756396 - Ethylene glycol esters as photoactive agents (2004-06-29),
6. 6620929 - 1,3-Dipolar cycloadditions to polypyrrolic macrocycles (2003-09-16),
7. 6331235 - Chiral separation of benzoporphyrin derivative mono-and di-acids by laser-induced fluorescence capillary electrophoresis (2001-12-18),
8. 6153639 - Ethylene glycol esters as photoactive agents (2000-11-28),
9. 5990149 - Class of benzoporphyrin derivative photoactive compounds (1999-11-23),
10. 5929105 - Ethylene glycol esters as photoactive agents (1999-07-27),
11. 5880145 - Class of benzoporphyrin derivative photoactive compounds (1999-03-09),
12. 5399583 - Method of treating skin diseases (1995-03-21),
13. 5283255 - Wavelength-specific cytotoxic agents (1994-02-01),
14. 5171749 - Wavelength-specific cytotoxic agents (1992-12-15),
15. 5095030 - Wavelength-specific cytotoxic agents (1992-03-10),

Title: Ethan D Sternberg: Innovator in Photodynamic Therapy

Introduction

Ethan D Sternberg is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of photodynamic therapy, holding a total of 16 patents. His work focuses on developing novel compounds and methods that enhance the effectiveness of phototherapy.

Latest Patents

Among his latest patents are innovative compounds such as ethylene glycol esters, which serve as photoactive agents. These new compounds are useful in photodynamic therapy and include their 1,4-diene isomers, as well as metallated, labeled, and conjugated forms. Additionally, he has developed methods and compositions for photo-crosslinking photoactive compounds to target tissue. This invention discloses novel photoactive compounds that can be crosslinked to target substrates, along with methods for their preparation and use.

Career Highlights

Ethan has worked with esteemed organizations, including the University of British Columbia and QLT Phototherapeutics, Inc. His career has been marked by a commitment to advancing medical technologies through innovative research and development.

Collaborations

Ethan has collaborated with notable individuals in his field, including David H Dolphin and Julia G Levy. Their combined expertise has contributed to the success of his projects and patents.

Conclusion

Ethan D Sternberg is a key figure in the advancement of photodynamic therapy, with a strong portfolio of patents and collaborations. His innovative work continues to impact the medical field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…